Corvus Pharmaceuticals Inc (CRVS)
2.06
-0.01
(-0.48%)
USD |
NASDAQ |
May 24, 15:42
Corvus Pharmaceuticals Price to Book Value: 3.862 for May 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 23, 2024 | 3.881 |
| May 22, 2024 | 4.012 |
| May 21, 2024 | 4.087 |
| May 20, 2024 | 4.275 |
| May 17, 2024 | 4.293 |
| May 16, 2024 | 4.106 |
| May 15, 2024 | 4.162 |
| May 14, 2024 | 4.237 |
| May 13, 2024 | 3.956 |
| May 10, 2024 | 3.900 |
| May 09, 2024 | 3.806 |
| May 08, 2024 | 3.675 |
| May 07, 2024 | 3.150 |
| May 06, 2024 | 3.581 |
| May 03, 2024 | 2.822 |
| May 02, 2024 | 2.543 |
| May 01, 2024 | 2.366 |
| April 30, 2024 | 2.278 |
| April 29, 2024 | 2.322 |
| April 26, 2024 | 2.131 |
| April 25, 2024 | 2.175 |
| April 24, 2024 | 2.219 |
| April 23, 2024 | 2.249 |
| April 22, 2024 | 2.116 |
| April 19, 2024 | 2.058 |
| Date | Value |
|---|---|
| April 18, 2024 | 2.072 |
| April 17, 2024 | 1.999 |
| April 16, 2024 | 2.161 |
| April 15, 2024 | 2.161 |
| April 12, 2024 | 2.249 |
| April 11, 2024 | 2.293 |
| April 10, 2024 | 2.219 |
| April 09, 2024 | 2.396 |
| April 08, 2024 | 2.513 |
| April 05, 2024 | 2.572 |
| April 04, 2024 | 2.484 |
| April 03, 2024 | 2.572 |
| April 02, 2024 | 2.734 |
| April 01, 2024 | 2.734 |
| March 28, 2024 | 2.256 |
| March 27, 2024 | 2.269 |
| March 26, 2024 | 2.231 |
| March 25, 2024 | 2.231 |
| March 22, 2024 | 2.269 |
| March 21, 2024 | 2.332 |
| March 20, 2024 | 2.345 |
| March 19, 2024 | 2.485 |
| March 18, 2024 | 2.409 |
| March 15, 2024 | 2.409 |
| March 14, 2024 | 2.383 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4096
Minimum
Sep 27 2022
4.293
Maximum
May 17 2024
1.509
Average
1.331
Median
Oct 18 2019
Price to Book Value Benchmarks
| Cyclacel Pharmaceuticals Inc | -- |
| Enanta Pharmaceuticals Inc | 1.526 |
| Oragenics Inc | 9.807 |
| Nanoviricides Inc | 2.451 |
| MAIA Biotechnology Inc | -- |
Price to Book Value Related Metrics
| Price | 2.06 |
| Earnings Yield | -24.76% |
| Market Cap | 128.86M |